Literature DB >> 23759662

Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach.

Johannes A Langendijk1, Philippe Lambin, Dirk De Ruysscher, Joachim Widder, Mike Bos, Marcel Verheij.   

Abstract

Most new radiation techniques, have been introduced primarily to reduce the dose to normal tissues in order to prevent radiation-induced side effects. Radiotherapy with protons is such a radiation technique that due to its superior beam properties compared to photons enables better sparing of normal tissues. This paper describes a stepwise methodology to select patients for proton therapy when the primary aim is to reduce side effects. This method has been accepted by the Dutch health authorities to select patients for proton therapy. In addition, an alternative method is described in case randomised controlled trials are considered not appropriate.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  NTCP-models; Patient selection; Proton therapy; Randomisation

Mesh:

Substances:

Year:  2013        PMID: 23759662     DOI: 10.1016/j.radonc.2013.05.007

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  107 in total

1.  Developing Predictive or Prognostic Biomarkers for Charged Particle Radiotherapy.

Authors:  Michael D Story; Jing Wang
Journal:  Int J Part Ther       Date:  2018

2.  Comparison of human lung cancer cell radiosensitivity after irradiations with therapeutic protons and carbon ions.

Authors:  Otilija D Keta; Danijela V Todorović; Tanja M Bulat; Pablo Ga Cirrone; Francesco Romano; Giacomo Cuttone; Ivan M Petrović; Aleksandra M Ristić Fira
Journal:  Exp Biol Med (Maywood)       Date:  2016-09-15

Review 3.  Personalized radiotherapy: concepts, biomarkers and trial design.

Authors:  A H Ree; K R Redalen
Journal:  Br J Radiol       Date:  2015-05-20       Impact factor: 3.039

4.  SEOR recommendations on the use of protons.

Authors:  M Lloret-Saez-Bravo; J Giralt-L de Sagredo; J Contreras-Martinez; C Ferrer-Albiach
Journal:  Clin Transl Oncol       Date:  2019-08-12       Impact factor: 3.405

5.  [Proton therapy not superior to IMRT in locally advanced NSCLC].

Authors:  Almut Dutz; Esther G C Troost; Steffen Löck
Journal:  Strahlenther Onkol       Date:  2018-08       Impact factor: 3.621

6.  A prospective study comparing the predictions of doctors versus models for treatment outcome of lung cancer patients: a step toward individualized care and shared decision making.

Authors:  Cary Oberije; Georgi Nalbantov; Andre Dekker; Liesbeth Boersma; Jacques Borger; Bart Reymen; Angela van Baardwijk; Rinus Wanders; Dirk De Ruysscher; Ewout Steyerberg; Anne-Marie Dingemans; Philippe Lambin
Journal:  Radiother Oncol       Date:  2014-05-17       Impact factor: 6.280

Review 7.  Proton therapy for the treatment of children with CNS malignancies.

Authors:  Radhika Sreeraman; Daniel J Indelicato
Journal:  CNS Oncol       Date:  2014-03

8.  Unresectable Ameloblastoma Successfully Treated with Definitive Proton Therapy.

Authors:  Francesco Dionisi; Maurizio Amichetti; Carlo Algranati; Irene Giacomelli; Mattia Barbareschi; Mauro Recla; Cesare Grandi
Journal:  Int J Part Ther       Date:  2017-09-26

Review 9.  Radiation oncology in the era of precision medicine.

Authors:  Michael Baumann; Mechthild Krause; Jens Overgaard; Jürgen Debus; Søren M Bentzen; Juliane Daartz; Christian Richter; Daniel Zips; Thomas Bortfeld
Journal:  Nat Rev Cancer       Date:  2016-03-18       Impact factor: 60.716

10.  Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysis.

Authors:  Pierre Blanchard; Adam S Garden; G Brandon Gunn; David I Rosenthal; William H Morrison; Mike Hernandez; Joseph Crutison; Jack J Lee; Rong Ye; C David Fuller; Abdallah S R Mohamed; Kate A Hutcheson; Emma B Holliday; Nikhil G Thaker; Erich M Sturgis; Merrill S Kies; X Ronald Zhu; Radhe Mohan; Steven J Frank
Journal:  Radiother Oncol       Date:  2016-06-21       Impact factor: 6.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.